NCT00450424

Brief Summary

RATIONALE: The use of a CD-ROM may help patients with colorectal cancer or a family history of colorectal cancer make informed decisions about undergoing microsatellite instability (MSI) testing. PURPOSE: This randomized clinical trial is studying an educational CD-ROM to see how well it works compared with standard informed consent to assist decision-making about MSI testing in patients with colorectal cancer or a family history of colorectal cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
239

participants targeted

Target at P50-P75 for not_applicable colorectal-cancer

Timeline
Completed

Started Jun 2007

Longer than P75 for not_applicable colorectal-cancer

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2007

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2007

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

September 5, 2014

Completed
Last Updated

September 5, 2014

Status Verified

September 1, 2014

Enrollment Period

4.4 years

First QC Date

March 20, 2007

Results QC Date

August 5, 2014

Last Update Submit

September 4, 2014

Conditions

Keywords

colon cancerrectal cancerhereditary non-polyposis colon cancerrecurrent colon cancerstage I colon cancerstage IIA colon cancerstage IIB colon cancerstage IIIA colon cancerstage IIIB colon cancerstage IIIC colon cancerstage IVA colon cancerstage IVB colon cancerrecurrent rectal cancerstage I rectal cancerstage IIA rectal cancerstage IIB rectal cancerstage IIC rectal cancerstage IIIA rectal cancerstage IIIB rectal cancerstage IIIC rectal cancerstage IVA rectal cancerstage IVB rectal cancer

Outcome Measures

Primary Outcomes (1)

  • Impact of Standard Informed Consent vs CD-ROM Educational Intervention on Knowledge About Microsatellite Instability (MSI) Testing

    10-item true/false MSI knowledge survey developed by the oncologists on trial. (e.g., "Microsatellite Instability is found in every person that has had cancer."; "Microsatellite Instability may be caused by a permanent change in a gene that is inherited from a person's mother or father."). Participants can score anywhere from 0 (no questions answered correctly) to 10 (all questions answered correctly).

    2 weeks after enrollment

Secondary Outcomes (3)

  • Differential Impact of CD-ROM on Satisfaction With MSI Test Decision, Difficulty Making Decision & Decisional Conflict; Attitude; General & Cancer-related Distress; Discussions With Family About MSI Test & Familial Colorectal Cancer Risk

    at enrollment and 2 weeks after enrollment

  • Impact of Demographic Factors, Disease/Family History Characteristics, Family Support, and Cancer-related Distress on Satisfaction With and Completeness of the Informed Consent Process

    at enrollment and 2 weeks after enrollment

  • Patient Satisfaction With the Preparation to Make a Decision

    at enrollment and 2 weeks after enrollment

Study Arms (1)

Counseling

NO INTERVENTION

Participants will be given one of two counseling interventions regarding MSI testing: standard counseling or a CD-ROM intervention.

Other: counseling interventionOther: CD-ROM intervention

Interventions

Participants in the Counseling intervention will meet with the study health educator who will provide the participant with the standard MSI informed consent form and provide a brief, standardized explanation of the MSI test. At that time, the participant can ask any questions s/he wishes to ask. The patients will either sign (or not sign, if they do not consent to have the test, or wish to think further about the decision) after this discussion. Participants who have further questions will be referred to either the attending physician or the genetics counselor at each hospital site.

Counseling

Participants who are randomized to the CD-ROM condition will complete the baseline interview and then meet with the health educator who will provide the participant with the standard MSI consent form and provide a brief, standardized explanation of the MSI test. At that time, the participant can ask any questions s/he wishes to ask. Next, the participant will be provided with the CD-ROM to view on a laptop computer in the clinic. Participants will also be given a copy of the CD-ROM to take home and keep for future reference. The CD-ROM patients will sign (or not sign, if they do not consent or wish to think further about the decision) the consent form after this discussion.

Counseling

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Patient or family member meeting 1 of the following revised Bethesda colorectal cancer (CRC) criteria: * Diagnosis of colon or rectal cancer at \< 50 years of age * Diagnosis of \> 1 CRC at one time in the past * Diagnosis of ≥ 1 CRC at different times * Diagnosis of CRC and any other hereditary nonpolyposis colorectal cancer (HNPCC)-related cancers * Diagnosis of CRC in ≥ 2 first-degree or second-degree relatives with HNPCC-related tumor and ≥ 1 cancer diagnosed at \< 50 years of age * Diagnosis of CRC in ≥ 2 first- or second-degree relatives with HNPCC-related tumors, regardless of age * Diagnosis of CRC with pathologic features suggestive of microsatellite instability (MSI) and \< 60 years of age * Patients with CRC meeting the Amsterdam criteria defined below are ineligible: * Three relatives with CRC with 1 being a first-degree relative of the other 2 * Cases that span ≥ 2 generations * At least 1 CRC case diagnosed before 50 years of age PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (3)

Helen F. Graham Cancer Center at Christiana Hospital

Newark, Delaware, 19713, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Fox Chase Cancer Center - Philadelphia

Philadelphia, Pennsylvania, 19111-2497, United States

Location

Related Publications (2)

  • Manne SL, Meropol NJ, Weinberg DS, Vig H, Ali-Khan Catts Z, Manning C, Ross E, Shannon K, Chung DC. Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol. 2010 Mar 10;28(8):1366-72. doi: 10.1200/JCO.2009.25.0399. Epub 2010 Feb 8.

  • Hall MJ, Manne SL, Winkel G, Chung DS, Weinberg DS, Meropol NJ. Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):249-54. doi: 10.1158/1055-9965.EPI-10-0685. Epub 2011 Jan 6.

MeSH Terms

Conditions

Colorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisColonic NeoplasmsRectal Neoplasms

Interventions

Counseling

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDNA Repair-Deficiency DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Kristen Sorice
Organization
Fox Chase Cancer Center

Study Officials

  • Sharon Manne, PhD

    Fox Chase Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2007

First Posted

March 22, 2007

Study Start

June 1, 2007

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

September 5, 2014

Results First Posted

September 5, 2014

Record last verified: 2014-09

Locations